Literature DB >> 2055701

Distribution of very late activation integrins in the human cornea. An immunohistochemical study using monoclonal antibodies.

B Lauweryns1, J J van den Oord, R Volpes, B Foets, L Missotten.   

Abstract

There is growing evidence that cellular adhesion mechanisms characterized by cell-cell and cell-matrix interactions are a fundamental process in the immunobiology of the cornea. Interactions with various extracellular matrix components are mediated by the very late activation (VLA) subgroup of the integrin superfamily of adhesion molecules. The six different VLA dimers known thus far consist of a common beta 1 subunit and a variable alpha (1 to 6) subunit. They serve as receptors for laminin (alpha 3 and alpha 6), collagen (alpha 2 and alpha 3), and fibronectin (alpha 4 and alpha 5). Using in situ immunohistochemistry and monoclonal antibodies, the distribution of the common beta 1 and the variable alpha-chains of VLA molecules was studied in normal human cornea and in cases with scarring or subepithelial/retrocorneal fibrous tissue. Epithelial cells were VLA-beta 1 and VLA-alpha 2, -alpha 3, -alpha 4, -alpha 5, and -alpha 6 positive. This is consistent with their intercellular adhesion and may aid in their attachment to the basement membrane which is composed of collagen, laminin, and fibronectin. Keratocytes in normal stroma expressed only the common beta 1-chain and no detectable alpha-chains. In regions of scar or fibrous tissue, however, an upregulated expression of the alpha-chains was detected. The VLA- alpha 1, -alpha 3, -alpha 4, and -alpha 5 were expressed in young fibrous tissue; in older lesions, VLA- alpha 1, -alpha 2, -alpha 3, -alpha 4, and -alpha 5 could be detected. The corneal endothelium showed a strikingly strong positivity for all VLA integrins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055701

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

Review 1.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Why HLA-B27? My thirty-year quest: the Friedenwald lecture.

Authors:  James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

3.  Integrin: Basement membrane adhesion by corneal epithelial and endothelial cells.

Authors:  Tina B McKay; Ursula Schlötzer-Schrehardt; Sonali Pal-Ghosh; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2020-07-23       Impact factor: 3.467

4.  Adhesion molecule expression in bullous keratopathy.

Authors:  S N Zhu; B Nölle; G Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Influence of Vitamin D on Corneal Epithelial Cell Desmosomes and Hemidesmosomes.

Authors:  Xiaowen Lu; Mitchell A Watsky
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

6.  The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology.

Authors:  Sunil K Parapuram; William Hodge
Journal:  J Cell Commun Signal       Date:  2014-03-07       Impact factor: 5.782

Review 7.  Integrins: cell adhesives and modulators of cell function.

Authors:  F T Bosman
Journal:  Histochem J       Date:  1993-07

8.  Biochemically and topographically engineered poly(ethylene glycol) diacrylate hydrogels with biomimetic characteristics as substrates for human corneal epithelial cells.

Authors:  B Yañez-Soto; S J Liliensiek; C J Murphy; P F Nealey
Journal:  J Biomed Mater Res A       Date:  2012-12-18       Impact factor: 4.396

9.  Integrin-dependent neutrophil migration in the injured mouse cornea.

Authors:  Samuel D Hanlon; C Wayne Smith; Marika N Sauter; Alan R Burns
Journal:  Exp Eye Res       Date:  2014-01-24       Impact factor: 3.467

10.  Epithelial cell characteristics of cultured human limbal explants.

Authors:  A Joseph; A O R Powell-Richards; V A Shanmuganathan; H S Dua
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.